| Issue Date | 13 Dec 2021 - 15 Dec 2021 |
| Issue Size | ₹1398.30 Cr |
| Issue Price | ₹780-796 |
| Market Lot | 18 Shares |
| Shares on Offer | 4,597,200 |
| Registrar | KFintech |
| GMP | ₹215-220 |
| Kostak | ₹600 |
| Subject to Sauda | ₹8000 |
| Listing Date | 23 Dec 2021 |
| Listing Price | ₹1040 |
| Listing Gain% | 30.65 |
MedPlus was founded in 2006 by Gangadi Madhukar Reddy, our Managing Director and Chief Executive Officer, with the vision to set up a trusted pharmacy retail brand that offers genuine medicines and delivers better value to the customer by reducing inefficiencies in the supply chain using technology. The founder, Managing Director and Chief Executive Officer of our Company, Gangadi Madhukar Reddy, both a doctor and an entrepreneur, plays an instrumental role in the strategic direction and growth of our business. Our Company's shareholders include marquee investors, including Lavender Rose, belonging to the Warburg Pincus group, and affiliates of Premji Invest, and we maintain strong corporate governance and internal controls.
They operate 2,165 stores in 242 cities distributed across Tamil Nadu, Andhra Pradesh, Telangana, Karnataka, Odisha, West Bengal and Maharashtra as of June 30, 2021. We have a total of 14,762 permanent full-time in-house employees working for us in a range of business activities.
The operations include the manufacturing and contract manufacturing of private label pharmaceutical, wellness and FMCG products, wholesale and retail sale, import, distribution, and pathology diagnostic laboratory testing.
Gangadi Madhukar Reddy, Lone Furrow Investments Pvt Ltd, and Agilemed Investments Pvt Ltd are the company promoters.
| Particulars | 31-Mar-21 | 31-Mar-20 | 31-Mar-19 |
|---|---|---|---|
| Total Assets (In ₹ Millions) | 15,656.58 | 13,486.96 | 9,587.11 |
| Total Revenue (In ₹ Millions) | 30,908.14 | 28,878.87 | 22,849.40 |
| Profit After Tax (PAT) (In ₹ Millions) | 631.11 | 17.94 | 119.22 |
| Date | GMP | Kostak | Subject to Sauda |
|---|---|---|---|
| 16 Dec 2021 | ₹215-220 | ₹600 | ₹8000 |
| 14 Dec 2021 | ₹250-260 | ₹500 | ₹3200 |
| 09 Dec 2021 | ₹285-290 | ₹450 | ₹3000 |
| 08 Dec 2021 | ₹320-330 | ₹350 | ₹2800 |
| Strength |
|---|
| Weakness |
|---|
| Date & Time | QIB | NII | RII | Total |
|---|---|---|---|---|
| Day 1 - 15 Dec 2021 | 0.06 | 0.16 | 1.29 | 0.70 |
| Day 2 - 16 Dec 2021 | 0.09 | 0.50 | 2.64 | 1.46 |
| Day 3 - 17 Dec 2021 | 111.90 | 85.33 | 5.24 | 52.59 |
Please click the link below to check the IPO allotment status.
IPO Allotment StatusMedplus Health Services Limited IPO will open on 13 Dec 2021 and close on 15 Dec 2021.
Medplus Health Services Limited IPO will list on 23 Dec 2021.
The offer price of Medplus Health Services Limited IPO is ₹780-796.
The lot size of Medplus Health Services Limited IPO is 18.
The Grey Market Premium (GMP) price of Medplus Health Services Limited IPO is ₹215-220.
The Kostak price of Medplus Health Services Limited IPO is ₹600.
The Subject to Sauda price for Medplus Health Services Limited IPO is ₹8000.
Please Leave Your Message
Medplus Health Services Limited IPO Review/Comments